Oncologix Tech Inc (OCLG)

[Sooah]

* On the date of the event which requires filing of this Statement, reporting person Typenex Co-Investment, LLC (“Typenex”) has rights, under a Convertible Promissory Note and Warrant, to own an aggregate number of shares of the Issuer’s common stock which, except for a contractual cap on the amount of outstanding shares of the Issuer’s common stock that Typenex may own, would exceed such a cap. Typenex’s ownership cap is 9.99% of the Issuers outstanding shares. Thus, the number of shares of the Issuer’s common stock beneficially owned by Typenex as of the date of this filing was 16,961,051 shares, which is 9.99% of the 169,780,297 shares that were outstanding on that date (as reported in the Issuer’s Form 10-Q filed on January 16, 2015).